Haishun New Materials (300501): Both upstream and downstream are making efforts to expand the market in all directions
Haishun New Materials (300501) Annual Review Report: The increase in the main pharmaceutical packaging business led to a 20% increase in revenue and upstream and downstream expansion to cultivate new growth points
Review of the annual report of Haishun New Materials (300501): Higher raw material prices drag down the issuance of convertible bonds at net interest rates to expand production capacity
Haishun New Materials (300501): Leading pharmaceutical packaging companies actively expand into new consumption and new energy fields
Haishun Xincai (300501) Quarterly report comments: 21Q1-3 revenue year-on-year + 25.85% continue to dig product depth and breadth
Haishun New Materials (300501): steady growth in income the rise in raw material prices affects profits
Haishun New Materials (300501): 21H1 revenue and profits increase, lithium battery aluminum-plastic film is expected to become a new performance growth point
Haishun new material (300501): the growth rate of revenue and profit is eye-catching and continues to tap the depth and breadth of products.
Haishun New Materials (300501): booming production and sales lead to high income and profit to rebound
Haishun New material (300501): the subsidiary turns losses into profits and gradually verifies the inflection point judgment.
Haishun Xincai (300501): Q3 performance as scheduled high growth net interest rate significantly increased
海顺新材(300501):盈利弹性得到验证 现金流大幅改善
Haishun New Materials (300501) Co., Ltd. Comments: performance as scheduled high growth and fixed increase in the construction of high barrier composite material project
海顺新材(300501):业绩增速居高 盈利持续性得到验证
海顺新材(300501):定增投建高阻隔药包产能 高端产品增强竞争力
海顺新材(300501):盈利弹性初现 关注关联审评行业机会
海顺新材(300501):利润拐点显现 Q2业绩大幅提升
Haishun New Materials (300501): Policy dividends help leaders set sail, new opportunities are ahead
海顺新材(300501)首次覆盖报告:药包龙头厚积薄发 利润拐点显现
海顺新材(300501)事件点评:药品包装整合者进军日化包装领域